Scott Richards
Chief Executive Officer bei Mayne Pharma, Inc.
Vermögen: 6 Mio $ am 31.03.2024
Profil
Scott Richards is currently the Chief Executive Officer at Mayne Pharma, Inc. and Envision Sciences Pty Ltd.
He previously held the position of Chief Executive Officer, MD & Executive Director at Mayne Pharma Group Ltd.
from 2012 to 2022.
He also worked as the President-European Operations & Global Hospital at Intas Pharmaceuticals Ltd., President-Global Commercial Operations at Mayne Pharma Ltd., and President-EMEA at F H Faulding & Co. Ltd.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MAYNE PHARMA GROUP LTD.
1,50% | 04.10.2022 | 1 280 211 ( 1,50% ) | 6 Mio $ | 31.03.2024 |
Aktive Positionen von Scott Richards
| Unternehmen | Position | Beginn |
|---|---|---|
Mayne Pharma, Inc.
 Mayne Pharma, Inc. Pharmaceuticals: MajorHealth Technology Mayne Pharma, Inc. develops pharmaceutical products. Its services include pharmaceutical development, clinical trial materials, method development and validation, trace metals, stability, and microbiology services. The company was founded in 1994 and is headquartered in Greenville, NC. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Scott Richards
| Unternehmen | Position | Ende |
|---|---|---|
| MAYNE PHARMA GROUP LIMITED | Chief Executive Officer | 01.10.2022 |
Mayne Pharma Ltd.
 Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Mayne Pharma Ltd. manufactures pharmaceutical products. It distributes generic injectables for the oncology market. The company's competitors include Sandoz, Bedford Labs, and Ebewe. It was founded in November 2005 and is headquartered in Melbourne, Australia. | Corporate Officer/Principal | - |
| F H Faulding & Co. Ltd. | Corporate Officer/Principal | - |
Intas Pharmaceuticals Ltd.
 Intas Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Intas Pharmaceuticals Ltd. engages in developing, manufacturing, and marketing of pharmaceutical formulations. The firm offers pharmaceutical products for various therapeutic areas including neurology, psychiatry, cardiology, pain management, gastroenterology, diabetology, nephrology, oncology, urology, anti-infective therapy, dermatology, rheumatology and gynecology, infertility, respiratory system, hematology, and ophthalmology. The company was founded by Hasmukh Kesarichand Chudgar in May 31, 1985 and is headquartered in Ahmadabad, India. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MAYNE PHARMA GROUP LIMITED | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Mayne Pharma, Inc.
Mayne Pharma, Inc. Pharmaceuticals: MajorHealth Technology Mayne Pharma, Inc. develops pharmaceutical products. Its services include pharmaceutical development, clinical trial materials, method development and validation, trace metals, stability, and microbiology services. The company was founded in 1994 and is headquartered in Greenville, NC. | Health Technology |
Intas Pharmaceuticals Ltd.
Intas Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Intas Pharmaceuticals Ltd. engages in developing, manufacturing, and marketing of pharmaceutical formulations. The firm offers pharmaceutical products for various therapeutic areas including neurology, psychiatry, cardiology, pain management, gastroenterology, diabetology, nephrology, oncology, urology, anti-infective therapy, dermatology, rheumatology and gynecology, infertility, respiratory system, hematology, and ophthalmology. The company was founded by Hasmukh Kesarichand Chudgar in May 31, 1985 and is headquartered in Ahmadabad, India. | Health Technology |
Mayne Pharma Ltd.
Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Mayne Pharma Ltd. manufactures pharmaceutical products. It distributes generic injectables for the oncology market. The company's competitors include Sandoz, Bedford Labs, and Ebewe. It was founded in November 2005 and is headquartered in Melbourne, Australia. | Health Technology |
| F H Faulding & Co. Ltd. |
